Armita Mahdavi Gorabi
Overview
Explore the profile of Armita Mahdavi Gorabi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
740
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Aghazadeh Z, Sanaee Delir D, Gholamrezaie H, Sadoughi A, Asl A, Noori Sanami M, et al.
Curr Drug Discov Technol
. 2023 Apr;
20(4):e180423215957.
PMID: 37076459
Introduction: Recently, the coronavirus disease 2019 (COVID-19) infection, with a vast spectrum of clinical and paraclinical symptoms has been a major health concern worldwide. Therapeutical management of COVID-19 includes antiviral...
2.
Babaie F, Omraninava M, Mahdavi Gorabi A, Khosrojerdi A, Aslani S, Yazdchi A, et al.
Curr Genomics
. 2023 Feb;
23(3):163-174.
PMID: 36777004
Psoriasis is an organ-specific autoimmune disease characterized by the aberrant proliferation and differentiation of keratinocytes, leading to skin lesions. Abnormal immune responses mediated by T cells and dendritic cells and...
3.
Panahi Y, Mahdavi Gorabi A, Talaei S, Beiraghdar F, Akbarzadeh A, Tarhriz V, et al.
Virol J
. 2023 Feb;
20(1):23.
PMID: 36755327
Background: The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to plague the world. While COVID-19 is asymptomatic in most individuals, it can...
4.
Mahdavi Gorabi A, Ravari M, Sanaei M, Davaran S, Kesharwani P, Sahebkar A
Int Immunopharmacol
. 2022 Oct;
113(Pt A):109300.
PMID: 36252486
The early stages of melanoma could be treated promisingly by surgical resection; however, the challenge is in advanced cases in which targeted therapy could be an option. The expression of...
5.
Mardi P, Abdi F, Ehsani A, Seif E, Djalalinia S, Heshmati J, et al.
Front Endocrinol (Lausanne)
. 2022 Sep;
13:957136.
PMID: 36176470
Introduction: Novel atherogenic lipid indices, including non-high-density lipoprotein cholesterol (non-HDL-C) which is calculated by subtracting the HDL-C value from the total cholesterol level, atherogenic index (ratio between triglycerides (TG) and...
6.
Kiaie N, Mahdavi Gorabi A, Loveless R, Teng Y, Jamialahmadi T, Sahebkar A
Neurosci Biobehav Rev
. 2022 Jul;
140:104794.
PMID: 35902044
Cell therapeutic approaches focusing on the regeneration of damaged tissue have been a popular topic among researchers in recent years. In particular, self-repair scarring from the central nervous system (CNS)...
7.
Baygi F, Blome C, Smith A, Mohammadian Khonsari N, Agoushi A, Maghoul A, et al.
BMC Public Health
. 2022 Feb;
22(1):242.
PMID: 35123421
Background: There are increasing concerns about mental health consequences of the COVID-19 pandemic among seafarers. This study aims to assess the effects of the current global health pandemic on life...
8.
Mahdavi Gorabi A, Abbasifard M, Imani D, Aslani S, Razi B, Alizadeh S, et al.
Phytother Res
. 2021 Sep;
36(1):85-97.
PMID: 34586711
It has been suggested that curcumin is a potential agent for lowering the levels of C-reactive protein (CRP) and high-sensitivity CRP (hs-CRP), as markers of inflammation. In the current meta-analysis,...
9.
Sahebkar A, Kiaie N, Mahdavi Gorabi A, Mannarino M, Bianconi V, Jamialahmadi T, et al.
Prog Lipid Res
. 2021 Sep;
84:101127.
PMID: 34509516
The 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors, or statins, are administered as first line therapy for hypercholesterolemia, both in primary and secondary prevention. There is a growing body of evidence showing...
10.
Mahdavi Gorabi A, Kiaie N, Khosrojerdi A, Jamialahmadi T, Al-Rasadi K, Johnston T, et al.
Trends Cardiovasc Med
. 2021 Sep;
32(8):525-533.
PMID: 34492295
Mounting scientific evidence over decades has established that atherosclerosis is a chronic inflammatory disorder. Among the potentially critical sources of vascular inflammation during atherosclerosis are the components of pathogenic bacteria,...